prof. dr. M.J. (Maarten) Postma

Professor Global Health Economics UMCG & RUG

prof. dr. M.J. (Maarten) Postma


  1. 2018
  2. Flume, M., Bardou, M., Capri, S., Sola-Morales, O., Cunningham, D., Levin, L-A., ... Touchot, N. (2018). Approaches to manage 'affordability' of high budget impact medicines in key EU countries. Journal of market access & health policy, 6(1), [1478539].
  3. van Wijhe, M., Tulen, A. D., Korthals Altes, H., McDonald, S. A., de Melker, H. E., Postma, M. J., & Wallinga, J. (2018). Quantifying the impact of mass vaccination programmes on notified cases in the Netherlands. Epidemiology And Infection, 146(6), 716-722.
  4. 2017
  5. Kollef, M. H., Bassetti, M., Francois, B., Burnham, J., Dimopoulos, G., Garnacho-Montero, J., ... Wunderink, R. G. (2017). The intensive care medicine research agenda on multidrug-resistant bacteria, antibiotics, and stewardship. Intensive Care Medicine, 43(9), 1187-1197.
  6. Fugel, H-J., Nuijten, M., Postma, M., & Redekop, K. (2017). Economic Evaluation in Stratified Medicine: Methodological Issues and Challenges. In M. Jakovljevic, & T. Yamada (Eds.), Role of health economic data in policy making and reimbursement of new medical technologies (pp. 14-20). Frontiers Media SA.
  7. Das Neves Cavaco, A. M., Schaafsma, E., Bicer, B. K., Sahne, B. S., Volmer, D., Ozcelikay, G., ... Yegenoglu, S. (2017). Internet and computer use amongst european pharmacy undergraduates: Exploring similarities and differences. Farmacia, 65(3), 407-413.
  8. 2016
  9. Rours, G. I. J. G., Smith-Norowitz, T. A., Ditkowsky, J., Hammerschlag, M. R., Verkooyen, R. P., de Groot, R., ... Postma, M. (2016). Cost-effectiveness analysis of Chlamydia trachomatis screening in Dutch pregnant women. Pathogens and Global Health, 110(7-8), 292-302.
Previous 1 2 3 4 5 6 7 8 ...15 Next

ID: 193217